Cargando…
Telotristat ethyl reverses myxomatous changes in mice mitral valves
RATIONALE: Myxomatous mitral valve degeneration is a common pathological manifestation of mitral valve regurgitation, with or without valvular prolapse. In addition to similarities between naturally occurring and serotonergic valve degeneration, an increasing body of evidence has recently suggested...
Autores principales: | Wang, Xinmei, Kuban-Johnston, Danielle, Lapuerta, Pablo, Lacerda, Carla M. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386075/ https://www.ncbi.nlm.nih.gov/pubmed/35990981 http://dx.doi.org/10.3389/fcvm.2022.945672 |
Ejemplares similares
-
Mapping of the myxomatous mitral valve: The three-dimensional extension of mitral annular disjunction in surgically repaired mitral prolapse
por: Biondi, Raoul, et al.
Publicado: (2022) -
In Reply: Telotristat Ethyl for Patients With Carcinoid Syndrome Associated With Chest Pain and Hypertension
por: Jiang, Wenjun, et al.
Publicado: (2018) -
The Role of Transforming Growth Factor-β Signaling in Myxomatous Mitral Valve Degeneration
por: Tang, Qiyu, et al.
Publicado: (2022) -
Survival and Clinical Outcomes with Telotristat Ethyl in Patients with Carcinoid Syndrome
por: Metz, David C, et al.
Publicado: (2020) -
Myxomatous degeneration of the mitral valve
por: Neto, Felippe Lazar, et al.
Publicado: (2018)